Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Takkt AG

Start price
Target price
Perf. (%)
€15.64
18.05.22
€17.50
18.05.23
-0.64%
29.05.22

Standard Investments for future growth
Differentiated customer and product portfolio
Top 10 in its market
Higher risks for its business
Ellritze 
18.05.22 70%
buy
MBB SE

Start price
Target price
Perf. (%)
€116.20
18.05.22
€135.00
18.05.23
0.69%
29.05.22

Standard Investments for future growth
Differentiated customer and product portfolio
Higher risks for its business
Significant cyclical dependencies
Ellritze 
18.05.22 70%
buy
Tupperware Brands Corp.

Start price
Target price
Perf. (%)
€6.37
18.05.22
€12.00
18.05.23
-88.44%
19.05.23

Top 10 in its market
Known brand
Significant cyclical dependencies
tbackenh 
18.05.22 50%
buy
Rhythm Pharmaceuticals

Start price
Target price
Perf. (%)
€3.16
18.05.22
€15.00
18.05.23
292.41%
29.07.22

Could be worthwhile Investment >10% per year
Higher risks for its business
Risky balance sheet
tbackenh 
18.05.22 50%
buy
American Public Ed.

Start price
Target price
Perf. (%)
€13.40
18.05.22
€18.00
18.05.23
-57.09%
19.05.23

Could be worthwhile Investment >10% per year
Good culture
tbackenh 
18.05.22 50%
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€1.08
18.05.22
-
18.05.23
-3.43%
16.10.22

Risky Investment
michaelkr 
18.05.22 50%
buy
Forte Biosciences Inc.

Start price
Target price
Perf. (%)
€1.08
18.05.22
-
18.05.23
10.77%
28.05.22

Capable Management
Could be very worthwhile Investment >20% year
Few uniques
me8 
18.05.22 0%
buy
SMA Solar Technology AG

Start price
Target price
Perf. (%)
€44.26
18.05.22
-
18.05.23
5.47%
28.05.22

EBIT growth >5% per year expected
Higher EBIT margin than peer group
Valuable balance sheet
Could be very worthwhile Investment >20% year
kostojunior 
18.05.22 50%
buy
Vita 34 AG

Start price
Target price
Perf. (%)
€11.05
18.05.22
-
18.05.23
-0.45%
28.05.22

Very Future proof/growth oriented business model
Market Leader or Top 3
Could be very worthwhile Investment >20% year
Rising EBIT margin expected
kostojunior 
18.05.22 70%
buy
Biofrontera AG

Start price
Target price
Perf. (%)
€1.16
18.05.22
-
18.05.23
2.59%
28.05.22

Could be very worthwhile Investment >20% year
Undervalued
kostojunior 
18.05.22 30%
buy
SGL Carbon SE

Start price
Target price
Perf. (%)
€5.63
18.05.22
-
18.05.23
3.20%
28.05.22

Higher EBIT margin than peer group
EBIT growth >5% per year expected
Very Future proof/growth oriented business model
Revenue growth >5% per year expected
kostojunior 
18.05.22 60%
buy
Adler Real Estate AG

Start price
Target price
Perf. (%)
€4.56
17.05.22
-
17.05.23
-9.87%
28.05.22

Could be worthwhile Investment >10% per year
Capable Management
Few uniques
me8 
17.05.22 0%
buy
Plug Power Inc.

Start price
Target price
Perf. (%)
€14.20
16.05.22
-
16.05.25
-73.94%
11.03.24

Could be worthwhile Investment >10% per year
Lutz69 
16.05.22 50%
buy
Nel ASA

Start price
Target price
Perf. (%)
€1.28
16.05.22
-
16.05.25
29.14%
08.08.22

Could be worthwhile Investment >10% per year
Lutz69 
16.05.22 50%
sell
Aurora Cannabis Inc.

Start price
Target price
Perf. (%)
€2.87
16.05.22
-
16.05.23
-15.82%
24.05.22

Probably not worthwhile Investment
Very high cyclical dependencies
Below average Marketposition
Higher risks for its business
tinelchen 
16.05.22 0%
buy
Chimerix Inc.

Start price
Target price
Perf. (%)
€2.60
16.05.22
€3.00
16.05.23
-28.60%
28.05.22

Could be worthwhile Investment >10% per year
Capable Management
Little innovation
me8 
16.05.22 0%
buy
Vertex Energy Inc.

Start price
Target price
Perf. (%)
€13.26
16.05.22
€26.00
16.05.23
2.97%
30.05.22

Could be very worthwhile Investment >20% year
DomRuinart 
16.05.22 50%
buy
Nel ASA

Start price
Target price
Perf. (%)
€1.29
16.05.22
-
16.05.23
3.37%
11.07.22

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Mori8 
16.05.22 50%
buy
Stratasys Inc.

Start price
Target price
Perf. (%)
€17.10
16.05.22
-
16.05.23
-0.15%
10.06.22

Mori8 
16.05.22 50%
buy
Axsome Therapeutics Inc

Start price
Target price
Perf. (%)
€28.60
16.05.22
-
16.05.23
-14.58%
28.05.22

Risky Investment
Vassago1 
16.05.22 50%
buy
First Majestic Silver Corp.

Start price
Target price
Perf. (%)
€7.90
16.05.22
-
16.05.23
0.23%
28.05.22

Undervalued
Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Top 10 in its market
torment69 
16.05.22 0%
buy
Steico SE

Start price
Target price
Perf. (%)
€86.30
15.05.22
€100.00
15.05.23
-51.97%
19.12.22

Could be worthwhile Investment >10% per year
Top 10 in its market
Future proof or reliable business model
Traumtanz 
15.05.22 50%
sell
Pacific Biosciences of California Inc.

Start price
Target price
Perf. (%)
€5.42
15.05.22
-
15.05.23
81.90%
24.04.23

Risky Investment
Growths slower than the competition
Lokrim 
15.05.22 20%
sell
Nautilus Inc.

Start price
Target price
Perf. (%)
€2.40
15.05.22
-
15.05.23
-49.99%
24.04.23

Probably not worthwhile Investment
Lokrim 
15.05.22 20%
sell
StoneCo Ltd

Start price
Target price
Perf. (%)
€8.59
15.05.22
-
15.05.23
24.05%
24.04.23

Probably not worthwhile Investment
Lokrim 
15.05.22 20%